Loghman Pharmaceuticals
.png) | |
| Company type | Public |
|---|---|
| TSE: DLGM1 ISIN: IRO1DLGM0000 | |
| Industry | |
| Founded | 1968 |
| Headquarters | Tehran, Iran |
Area served | Worldwide |
Key people | Khosro Davari, chief executive officer Alireza Zohrevand, Chairman |
| Products | Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy) |
  44 Billion IRR (2009) | |
| Total assets | 437 Billion IRR (2009) |
| Website | www.loghmanpharma.com |
Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.[1]
History
[edit]Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.[2]
The company has been listed on the Tehran Stock Exchange since 1997.[3]
products
[edit]- Acetaminophen+Codeine
- Amoxicillin
- Azithromycin
- Buspirone
- Carbamazepine
- Cefalexin
- Cefazolin
- Cefepime
- Cefixime
- Ceftazidime
- Ceftriaxone
- Cefuroxime
- Cefalexin
- Diazepam
- Erythromycin
- Fluconazole
- Sodium Fluoride
- Ibuprofen
- Indomethacin
- Lorazepam
- Losartan Potassium
- Meropenem
- Methimazole
- Nortriptyline
- Phenytoin
- Sodium Fluoride
- Sorbitol
- Valsartan
Development plan
[edit]See also
[edit]References
[edit]- ^ "Stocks". Archived from the original on October 5, 2012.
- ^ "شرکت دارویی بهداشتی لقمان". Archived from the original on 2013-07-08. Retrieved 2013-06-08.
- ^ "Dlgm1 37,480".
 | This Iran-related article is a stub. You can help Wikipedia by expanding it. |